European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

David Coghill (Lead / Corresponding author), Tobias Banaschewski, Michel Lecendreux, Cesar Soutullo, Mats Johnson, Alessandro Zuddas, Colleen Anderson, Richard Civil, Nicholas Higgins, Andrew Lyne, Liza Squires

    Research output: Contribution to journalArticlepeer-review

    95 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder'. Together they form a unique fingerprint.

    Medicine & Life Sciences